Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - NEWRIVER REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BRITVIC PLC - Ordinary Shares
-
Form 8.5 (EPT/RI) - Warpaint London Plc
-
"A DATE WITH HARBIN, A HEARTWARMING ICE CITY" Asia-Pacific Media Tour Was Held
-
Form 8.5 (EPT/RI) - Brand Architekts Group plc
-
"A DATE WITH HARBIN, A HEARTWARMING ICE CITY" Asia-Pacific Media Tour Was Held
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers
-
Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers
-
Kalmar’s electric reachstacker helping APM Terminals progress towards net zero at SCCT in Egypt
-
Fly Play hf.: PLAY Breaks Its Record for Best Load Factor in November
-
Offer Update – Extension of Early Bird Discount Period
-
Sydbank share buyback programme: transactions in week 49
-
Alm. Brand A/S – Weekly report on share buybacks
-
Prepayments, Realkredit Danmark A/S
-
Heimar hf.: Regular Notification of Share Buybacks in Accordance with the Buyback Program
-
tiakis Biotech AG Reports Clinical Phase Ib/II Trial Results of Tiprelestat for the Treatment of Hospitalized COVID-19 Patients
-
Apollo and Santander Partner on a $370 Million Infrastructure Portfolio Financing
-
AI hyperscaler Nscale secures $155 million in Series A funding to accelerate AI infrastructure expansion and meet soaring demand for large-scale compute
-
Danske Bank share buy-back programme: Transactions in week 49
-
tiakis Biotech AG Reports Clinical Phase Ib/II Trial Results of Tiprelestat for the Treatment of Hospitalized COVID-19 Patients
-
Share buyback programme - week 49
-
European Energy A/S: Financial Calendar 2025
-
Preliminary data on early redemptions (prepayments)
-
Prepayments (CK93) - Totalkredit A/S
-
Prepayments (CK93) - Nykredit Realkredit A/S
-
Form 8.5 (EPT/RI)-Aquis Exchange plc
-
Net Asset Value(s)
-
Advantest Launches KGD Test Cell for Power Semiconductors
-
ASM receives 2024 Excellent Performance Award from TSMC
-
Discover the CPT (iComPneT) Listing on XT
-
Discover the APX Listing on XT
-
MINING LEASE APPLICATION SUBMITTED FOR NORRA KÄRR
-
ALSTOM SA: Alstom to supply 35 additional RER NG trains for the RER E line on the Île-de-France Mobilités network
-
AAVantgarde presents safety data of the first two subjects dosed in the LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B at FLORetina 2024
-
Caledonia Mining Corporation Plc: Purchase of Securities by Director
-
Pulsar Helium Commences Field Activities for Deepening the Jetstream #1 Appraisal Well at the Topaz Project in Minnesota, USA
-
MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance
-
Shell plc Third Quarter 2024 Euro and GBP Equivalent Dividend Payments
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 5)
-
INVL Partner Global Real Estate Fund I raises additional USD 1.19 million
-
Bionical Emas sells EMAS Pharma to Kester Capital following strategic review
-
Kester Capital backs experienced management team in acquiring EMAS Pharma
-
Moma update
-
Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders
-
Vow ASA: Last day of the subscription period in the rights issue
-
Transaction in Own Shares
-
Subsea7 share repurchases
